C aveolae, specialised regions of the cell membrane which have been detected in a wide range of mammalian cells, have not been described in bone cells. They are plasmalemmal invaginations, 50 to 100 nm in size, characterised by the presence of the structural protein, caveolin, which exists as three subtypes. Caveolin-1 and caveolin-2 are expressed in a wide range of cell types whereas caveolin-3 is thought to be a muscle-specific subtype. There is little information on the precise function of caveolae, but it has been proposed that they play an important role in signal transduction.
Identification of caveolae and detection of caveolin in normal human osteoblasts
From the Johns Hopkins University, Baltimore, USA C aveolae, specialised regions of the cell membrane which have been detected in a wide range of mammalian cells, have not been described in bone cells. They are plasmalemmal invaginations, 50 to 100 nm in size, characterised by the presence of the structural protein, caveolin, which exists as three subtypes. Caveolin-1 and caveolin-2 are expressed in a wide range of cell types whereas caveolin-3 is thought to be a muscle-specific subtype. There is little information on the precise function of caveolae, but it has been proposed that they play an important role in signal transduction.
As the principal bone-producing cell, the osteoblast has been widely studied in an effort to understand the signalling pathways by which it responds to extracellular stimuli. Our aim in this study was to identify caveolae and their structural protein caveolin in normal human osteoblasts, and to determine which subtypes of caveolin were present. Confocal microscopy showed staining which was associated with the plasma membrane. Transmission electron microscopy revealed the presence of membrane invaginations of 50 to 100 nm, consistent with the appearance of caveolae. Finally, we isolated protein from these osteoblasts, and performed Western blotting using anti-caveolin primary antibodies. This revealed the presence of caveolin-1 and -2, while caveolin-3 was absent.
The identification of these structures and their associated protein may provide a significant contribution to our further understanding of signal transduction pathways in osteoblasts. Bone mass is determined by the relative rates of formation of new bone or resorption of existing bone. 1 External stimuli, including hormones 2 or mechanical stimulation, 3, 4 tip the balance in favour of the production of bone, while a lack of these stimuli can result in resorption of bone. 5, 6 As the principal bone-producing cell, the osteoblast has been studied in great detail in regard to the various cellular and biochemical mechanisms by which signal transduction occurs. Osteoblasts, however, are not the only cells which respond to these types of external stimulus. For example, endothelial cells respond to mechanical stimulation caused by changes in blood flow 7 and also to changes in their hormonal milieu. 8 In both of these examples, caveolae and their associated protein, caveolin, have been shown to play an important role. 7, 8 Caveolae are flask-shaped invaginations of the plasma membrane 50 to 100 nm in size, which have been identified in a wide range of mammalian cells, although not in osteoblasts. They were initially described several decades ago, although their function was unknown. More recently, they have been proposed as having an important function in signal transduction, in addition to playing putative roles in transcytosis and potocytosis. [9] [10] [11] Caveolae are characterised by the 18-22 kDa transmembrane protein, caveolin, several different isoforms of which have been identified (caveolin-1, -2 and -3), specific to certain tissues. Caveolin-1 and caveolin-2 are expressed ubiquitously, although there is no report of their identification in osteoblasts. They are most highly expressed in tissues such as endothelium (caveolin-1) and adipose tissue (caveolin-2). Caveolin-3, on the other hand, is considered to be a muscle-specific isoform 12, 13 although it has recently been reported to be present in both astroglial cells 14 and chondrocytes. 15, 16 These proteins, and the cell-surface structures, caveolae, in which they are found, are currently the subjects of intense study in other organ systems. Neither caveolae nor the protein caveolin, however, have been found in osteoblasts. Our aim was to identify caveolae in normal human osteoblasts and to define the particular isoforms of caveolin which they express.
Materials and Methods

Reagents.
Lysis buffer consisted of stock solution (150 mM NaCl, 50 mM Tris (pH 7.6), 1mM EDTA, 0.1% sodium dodecyl sulphate (SDS), 1% deoxycholic acid Na + , 1% Triton X-100) to which was added 110 mM phenylmethylsulphonyl fluoride (PMSF), 1 M sodium fluoride, 100 mM sodium orthovanadate, 10 mg/ml of leupeptin and 10 mg/ml of aprotinin. The 2ϫ loading buffer contained 100 mM Tris (ph 6.8), 200 mM dithiothreitol (DTT), 4% SDS, 20% glycerol, and 0.2% bromophenol blue. Electrophoresis running buffer contained 250 mM glycine, 25 mM Tris, and 3.5 mM SDS. Towbin transfer buffer contained 190 mM glycine and 25mM Tris in 20% methanol. Cell culture. Normal human osteoblasts were isolated from human bone chips by serial collagenase digestion. 17 The isolated cells were passaged, seeded on to five T75 flasks and cultured in HY medium 18 under standard culture conditions (37°C, 5% CO 2 ). They were grown to confluence in HY medium, and were then harvested using sterile 0.25% trypsin in Hanks' balanced salt solution (HBSS). The cells were confirmed as being osteoblasts by their production of alkaline phosphatase and collagen I, as demonstrated by immunocytochemical staining. The activity of alkaline phosphatase was verified by a p-nitrophenylphosphate conversion assay (Sigma Diagnostics, St Louis, Missouri). In addition, they were shown to produce the osteoblast-specific protein osteocalcin by immunoradioactive assay of the supernatant (Immunotopics Inc, San Clemente, California). In this study, cells were used between passages 3 and 8. Electron microscopy. After characterisation, the osteoblasts were cultured in HY medium in a 35 mm Petri dish.
Once they approached confluence they were washed twice in phosphate-buffered saline (PBS) (pH 7.4) and fixed in 2.5% gluteraldehyde for 30 minutes at room temperature. They were washed three times in 0.1 M cacodylate, and postfixed in reduced osmium tetroxide (1% OsO 4 , 1% K 4 Fe(CN) 6 ) for 30 minutes at 4°C. After three further washes in distilled water, the cells were stained with 2% uranyl acetate for 30 minutes. They were dehydrated with 50% ethanol for five minutes, 70% ethanol for five minutes, and 90% ethanol for five minutes, and finally treated three times for ten minutes each in freshly opened 100% ethanol. They were treated overnight with complete eponate on a rocking platform, followed the next day by three changes of eponate, with at least one hour between changes. They were then incubated at 37°C for two days, and finally overnight at 60°C. The cells were then sectioned, mounted and viewed using an Amray transmission electron microscope. Confocal microscopy. After their initial passage, cells were seeded on to sterile glass microscope slides in a 15 cm Petri dish, and cultured overnight in HY medium at 37°C and 5% CO 2 . The following day when they had become adherent to the slides they were removed from the culture medium, washed with PBS, and fixed with cold 50% methanol and 50% acetone for 15 minutes. All procedures were carried out at 4°C. After air-drying for 20 minutes, they were washed twice with PBS, and then blocked with 10% normal goat serum and 0.3% Triton-X in PBS for 30 minutes at room temperature. They were then washed three times with PBS. The cells were exposed to mouse monoclonal anti-caveolin antibody (dilution 1:50) for one hour at room temperature. For a negative control, some identical cells were exposed to PBS alone for the same period of time. Both sets of cells were then washed four times with PBS, before being exposed to FITC-labelled anti-mouse secondary antibody (dilution 1:50) for 45 minutes at room temperature. Finally, they were washed a further five times with PBS. The slides were postfixed with Vectashield mounting medium (Vector Labs Inc, Burlingame, California), covered with glass coverslips and subjected to confocal microscopy. Protein preparation. After reaching confluence, the osteoblast monolayers were washed twice with cold PBS. Approximately 10 million cells were harvested from five T75 flasks by treatment with 0.1M EDTA in PBS. After pelleting the cells by centrifugation and discarding the supernatant, they were dissolved in cold freshly-prepared lysis buffer. The lysate was centrifuged for 30 minutes at 16 000ϫ g and the supernatant was saved on ice for further processing. The protein concentration of the supernatant was measured using a modified Lowry method (Biorad, Hercules, California). Protein solutions for each of the positive controls were prepared in a similar fashion. Bovine aortic endothelial (BAE) cells were used as a positive control for caveolin-1, and purified murine myocytes for caveolin-3. Previous studies have confirmed that these tissues are suitable positive controls for these subtypes of caveolin. Commercially available mouse fibroblast (RSV-3T3) lysate, supplied by Transduction Laboratories (Lexington, Kentucky), was used as the positive control for caveolin-2. Western blot analysis. Aliquots of the osteoblast cell lysate and the appropriate controls, each containing 50 g of protein, were added to an equal volume of 2ϫ loading buffer, and boiled for five minutes. After centrifugation for 30 seconds, each solution was loaded on a 10-lane 4-15% Tris-HC1 electrophoresis gel (Biorad). This was electrophoresed for one hour at 100V. It was then equilibrated in Towbin transfer buffer for 15 minutes, before being transferred to nitrocellulose paper (Biorad) for one hour at 15V. The paper was blocked with 5% non-fat dried milk in TBS buffer overnight at 4°C to prevent non-specific binding. It was then incubated for one hour at room temperature with either caveolin-1, caveolin-2 or caveolin-3 murine monoclonal antibodies (Transduction Laboratories), and washed three times with TBS buffer containing 0.1% Tween-20. This was followed by incubation for one hour with HRPconjugated anti-mouse antibody (Transduction Laboratories) and three further washes. The paper was then treated with ECL emulsion (Amersham UK, Little Chalfont, UK) for one minute, and the labelled bands were visualised by exposure to x-ray film.
Results
When examined by light microscopy, the isolated cells grown in monolayer culture appeared to be stellate and stained positively for both collagen I and alkaline phosphatase. The p-nitrophenylphosphate conversion assay confirmed the presence of alkaline phosphatase activity, and significant levels of the osteoblast-specific protein, osteocalcin, were identified in the supernatants (40 ng/mg of protein). These findings were consistent with the expression of an osteoblast-like phenotype, and supported the concept that the isolated cell population consisted predominantly of osteoblasts. Ultrastructural investigation of the osteoblasts by transmission electron microscopy revealed numerous flask-like invaginations of the plasma membrane (Fig. 1 ). These were approximately 50 to 100 nm in diameter, and appeared identical to that of caveolae seen in other tissues, such as endothelium and cartilage. As has been described in other cell types, at a lower magnification (ϫ 27 500) the caveolae appeared to be clustered together at irregular intervals along the plasma membrane (Fig. 1a) . In the sections examined, however, there did not appear to be any regular association with specific intracellular structures, such as the endoplasmic reticulum or mitochondria. At a higher magnification (ϫ 74 000) the structure of the caveolae as infoldings of the plasma membrane could be clearly identified, their flask-shaped walls being continuous with those of the osteoblasts themselves (Fig. 1b) .
In order to identify the caveolae-associated protein, caveolin, osteoblasts were fixed and exposed to an anti-caveolin primary antibody, followed by an FITC-labelled secondary antibody. Microscopic examination of these cells showed marked fluorescence. By contrast, identical specimens in which the primary antibody had been omitted, showed much lower levels of fluorescence, excluding the possibility that the effect was due to non-specific labelling by the secondary antibody. Further examination of the specimens using confocal microscopy allowed the cellular distribution of caveolin to be visualised (Fig. 2) . The Transmission electron micrographs of cultured normal human osteoblasts showing a) the membranes of two adjacent cells (ϫ27 500) and b) a cluster of membrane structures 50 to 100 nm in size (arrowed). These flask-shaped invaginations are likely to be caveolae (ϫ74 000).
Fig. 2
Confocal micrograph of osteoblasts labelled with FITC-conjugated antibodies to human caveolin. There is marked staining of the labelled osteoblasts, mainly associated with the cell membrane.
observed fluorescence of the labelled cells was primarily associated with the plasma membrane, supporting the findings of the transmission electron micrographs. In addition to this membrane staining, there was also some punctate staining of the cytoplasm, although there was no detectable staining of the osteoblast nuclei. By contrast, the negative controls showed only slight staining of the cytoplasm, while the most striking feature was the absence of staining of the membrane. Western blot using monoclonal caveolin-1 antibody revealed a single positive band in the osteoblast lanes, corresponding to the 22 kDa protein, caveolin-1 (Fig. 3a) . The positive control lane contained BAE cell lysate, which has been shown to contain caveolin-1. This lane also had a positive band at the same level. There was no detectable band in the negative control lane, which contained cell lysate of cardiomyocytes. Myocytes have been shown to contain caveolin-3 but not caveolin-1. By contrast, when an identical Western blot was probed with caveolin-3 antibody, there were no visible bands in the human osteoblast lanes (Fig. 3b) . In this case, there was a strong band in the myocyte lane at 18 kDa, corresponding to caveolin-3. BAE cells, which do not contain caveolin-3, did not produce a positive band. Western blot using caveolin-2 antibody also revealed a positive band corresponding to a 20 kDa protein in the osteoblast lanes (Fig. 4) . This was consistent with the co-expression of caveolin-2 with caveolin-1, a situation which has been observed in other tissues.
Discussion
Although caveolae have been described in other tissues, there is no account of their presence, or that of the associated protein caveolin, in bone cells. In our study, using transmission electron microscopy, we have demonstrated plasmalemmal structures in normal human osteoblasts which are identical in appearance to caveolae, as described in other tissues. Using confocal microscopy, we have confirmed that the osteoblasts express the protein caveolin, and have shown that it is predominantly associated with the cell membrane. Finally, we have shown that normal human osteoblasts express the caveolin-1 and caveolin-2 isoforms of this protein, which have been identified in other nonmuscle tissues. Unlike chondrocytes and astroglial cells, however, osteoblasts do not contain caveolin-3.
Caveolae were first identified in epithelial and endothelial cells over 40 years ago, although their function has only recently been investigated. New methods have been devised to isolate caveolae-containing membrane fractions, 19, 20 and a family of three caveolae-associated proteins, the caveolins, has been discovered. 21 Caveolin-1 and caveolin-2 are expressed by many different tissues, and in many cases may coexist, forming a stable hetero-oligomeric complex. 22 Caveolin-3 is thought to be a musclespecific isoform, but recently it has been identified in chondrocytes and astroglial cells. [14] [15] [16] While it has been
proposed that caveolae and caveolin may play a role in lipid metabolism, as well as in the control of cell growth, many of the recent studies have focused on their role in signal transduction. A region near the N-terminal end of caveolin-1 has been identified as a scaffolding domain for corresponding regions on a variety of signalling molecules, such as receptors, G-proteins, and protein kinases. 23 In addition, studies have shown that many of these proteins, as well as the enzyme nitric oxide synthase, are more abundant in caveolae-enriched fractions. 24 Thus, it has been proposed that caveolae may act as organising sites, where proteins involved in signal transduction are compartmentalised and brought into proximity with cell-surface signalling receptors.
Recently, in studies aimed at elucidating signal transduction pathways in orthopaedics, nitric oxide (NO) has been identified as an important mediator in the regulation of the function of bone cells. 25, 26 It has been shown to be important in osteoblasts, 27, 28 which constitutively express the enzyme endothelial nitric oxide synthase (eNOS), 29 an isoform which produces low levels of NO in a calciumdependent manner. In particular, osteoblasts produce calcium-dependent NO in response to mechanical stimulation, whether by stretch, 30 or fluid shear, 31, 32 and it is likely that this is due to an increase in the activity of the eNOS isoform. The exact mechanism, however, by which this altered enzyme activity is produced remains unclear.
Osteoblasts are not the only cell type in which NO production is modulated by external stimuli. Endothelial cells have also been shown to respond to mechanical stimulation by a similar alteration of eNOS activity. 7 Since the eNOS isoform was originally identified in endothelial cells, much of the ongoing study of its location and mode of action has been carried out in this cell type. The activity of this calcium-dependent enzyme is regulated by intracellular interactions between calcium ions and calmodulin. More recently, eNOS has been localised to caveolae, 33 which are thought to serve as sites for the co-localisation of NOS-coupled signalling molecules, 34 and it has been
shown that the binding of eNOS to its corresponding caveolin-1 scaffolding domain modulates its production of NO. 35, 36 Thus, it is possible that in osteoblasts also, the localisation of eNOS to caveolae may provide an important regulation of the production of NO. In addition, its interaction with the protein caveolin may act in a reciprocal fashion with the calcium-calmodulin system. Caveolin-1 has also been shown in kidney cells to be associated with integrins, 37 a family of cell-surface proteins which attach the cell to structural proteins in the extracellular matrix. In fibroblasts caveolin has been shown to be important in integrin-mediated signalling and adhesion. 38 Integrins appear to play a role in mechanotransduction; in vitro studies in human osteoblast-like cells have shown that the distribution and expression of integrin are modulated by mechanical stimulation. 39 Thus, since it is the common denominator in a number of mechanicallymodulated pathways, it is possible that caveolin-1 may have an important role in mechanotransduction in osteoblasts. Interesting areas for further study may be in determining if there is co-localisation of eNOS or integrin-ß1 with caveolin in normal human osteoblasts, and if so, to investigate whether their relationship is modulated by mechanical strain. Although caveolae and their constituent protein, caveolin, have been well described in many tissues, this is the first description of their presence in bone cells. While the functional significance of these findings is not yet known, they raise exciting possibilities in regard to further study of signalling pathways in bone cells, and may provide a clue to the greater understanding of the response of osteoblasts to mechanical stimulation. This work was supported by the National Institute of Health grant KO8 HL-03238 and a grant-in-aid from the American Heart Association, both to JMH.
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